In early 2026, emerging research into the gut-eye axis is revealing how intestinal microbiota influence the activation of auto-reactive T-cells that eventually migrate to the uvea. These 2026 clinical insights have led to the introduction of medical-grade probiotic adjuncts designed to restore intestinal barrier integrity and reduce the systemic "leakage" of inflammatory markers. In early 2026,...